Dysfunctional uterine bleeding medical therapy: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 27: Line 27:
*:*:* Intrauterine progesterone
*:*:* Intrauterine progesterone


===Contraindicated medications===
{{MedCondContrAbs
|MedCond = Uterine bleeding | Norelgestromin and Ethinyl Estradiol |}}


==References==
==References==

Revision as of 17:06, 2 April 2015

Dysfunctional uterine bleeding Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Dysfunctional uterine bleeding from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Dysfunctional uterine bleeding medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Dysfunctional uterine bleeding medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Dysfunctional uterine bleeding medical therapy

CDC on Dysfunctional uterine bleeding medical therapy

Dysfunctional uterine bleeding medical therapy in the news

Blogs on Dysfunctional uterine bleeding medical therapy

Directions to Hospitals Treating Dysfunctional uterine bleeding

Risk calculators and risk factors for Dysfunctional uterine bleeding medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Vishnu Vardhan Serla M.B.B.S. [2]

Treatment

Management of dysfunctional uterine bleeding predominantly consists of reassurance, though mid-cycle estrogen and late-cycle progestin can be used for mid- and late-cycle bleeding respectively. Also, non-specific hormonal therapy such as combined estrogen and progestin can be given.

The goal of therapy should be to arrest bleeding, replace lost iron to avoid anemia, and prevent future bleeding.

In general;

  • IV estrogen, blood transfusion, IV fluids, curettage, hysterectomy or ligation of uterine artery are used to treat acute life-threatening bleeds.
  • Treatment of underlying etiologies.

Pharmacotherapy

Acute Pharmacotherapies

  • Oral contraceptives are used to treat nonacute bleeding.
    • Cyclic progesterone
    • Estrogen/progesterone
    • Other:
      • Fibrinolytic agents
      • Danazol
      • Tranexamic acid
      • Megestrol
      • GnRH analogs (Gonadotropin-releasing hormone)
      • Intrauterine progesterone

Contraindicated medications

Uterine bleeding is considered an absolute contraindication to the use of the following medications:

References

Template:WH Template:WS